Literature DB >> 20510722

Evaluation of hypercalcemia in relation to hyperparathyroidism.

Phillip K Pellitteri1.   

Abstract

Hypercalcemia, which results from the rate of calcium influx into the extracellular fluid exceeding the rate of calcium efflux from the extracellular fluid, has been reported as occurring in approximately 1% to 4% of the adult population in general, and anywhere from 0.5% to 3% of hospitalized adult populations. Hypercalcemia associated with primary hyperparathyroidism has frequently resulted in the development of pancreatitis and peptic ulcer disease; however, the pathophysiologic mechanism of this association remains uncertain. This article examines the etiology and differential diagnosis of hypercalcemia, in particular regarding its association with primary hyperparathyroidism. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510722     DOI: 10.1016/j.otc.2010.02.006

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

1.  Challenges in the differential diagnosis of hypercalcemia: A case of hypercalcemia with normal PTH level.

Authors:  Francesca Pellicciotti; Andrea Giusti; Maria Carolina Gelli; Salvatore Foderaro; Alberto Ferrari; Giulio Pioli
Journal:  World J Clin Oncol       Date:  2012-01-10

2.  Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling.

Authors:  Yefeng Wang; Divya R Gunashekar; Terrence J Adam; Rui Zhang
Journal:  Stud Health Technol Inform       Date:  2017

3.  Man of Steel Syndrome: Silicone and Mineral Oil Injections With Associated Hypercalcemia, Hypophosphatemia, and Proximal Muscle Weakness.

Authors:  Arash Shirvani; Nadine E Palermo; Michael F Holick
Journal:  JBMR Plus       Date:  2019-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.